Search

Van Allen, E. M., V. W. Lui, A. M. Egloff, E. M. Goetz, H. Li, J. T. Johnson, U. Duvvuri, et al. 2015. “Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma”. JAMA Oncol 1: 238-44.

Venteicher, A. S., I. Tirosh, C. Hebert, K. Yizhak, C. Neftel, M. G. Filbin, V. Hovestadt, et al. 2017. “Decoupling Genetics, Lineages, and Microenvironment in IDH-Mutant Gliomas by Single-Cell RNA-Seq”. Science 355.

Wang, L., M. S. Lawrence, Y. Wan, P. Stojanov, C. Sougnez, K. Stevenson, L. Werner, et al. 2011. “SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia”. N Engl J Med 365: 2497-506.

Xu, Q., P. K. Majumder, K. Ross, Y. Shim, T. R. Golub, M. Loda, and W. R. Sellers. 2007. “Identification of Prostate Cancer Modifier Pathways Using Parental Strain Expression Mapping”. Proc Natl Acad Sci U S A 104: 17771-6.

Hofman, Damon A, Jorge Ruiz-Orera, Ian Yannuzzi, Rakesh Murugesan, Adam Brown, Karl R Clauser, Alexandra L Condurat, et al. 2024. “Translation of Non-Canonical Open Reading Frames As a Cancer Cell Survival Mechanism in Childhood Medulloblastoma”. Mol Cell 84 (2): 261-76.

Parsons, H A, T Blewett, X Chu, S Sridhar, K Santos, K Xiong, V G Abramson, et al. 2023. “Circulating Tumor DNA Association With Residual Cancer Burden After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer in TBCRC 030”. Ann Oncol 34 (10): 899-906.

Ben-David, U., R. Beroukhim, and T. R. Golub. 2019. “Genomic Evolution of Cancer Models: Perils and Opportunities”. Nat Rev Cancer 19: 97-109.

Bray, M. A., S. M. Gustafsdottir, M. H. Rohban, S. Singh, V. Ljosa, K. L. Sokolnicki, J. A. Bittker, et al. 2017. “A Dataset of Images and Morphological Profiles of 30 000 Small-Molecule Treatments Using the Cell Painting Assay”. Gigascience 6: 1-5.

Chan, E. M., T. Shibue, J. M. McFarland, B. Gaeta, M. Ghandi, N. Dumont, A. Gonzalez, et al. 2019. “WRN Helicase Is a Synthetic Lethal Target in Microsatellite Unstable Cancers”. Nature 568: 551-56.

Chen, L., G. Alexe, N. V. Dharia, L. Ross, A. B. Iniguez, A. S. Conway, E. J. Wang, et al. 2018. “CRISPR-Cas9 Screen Reveals a MYCN-Amplified Neuroblastoma Dependency on EZH2”. J Clin Invest 128: 446-62.